Neogen Chemicals releases Q1FY27 earnings call recording for stakeholder review
Neogen Chemicals disclosed the outcome of its analysts and investors conference call held on July 27, 2026, discussing Q1FY27 results. The audio recording is publicly accessible on the company's website in compliance with SEBI Regulation 30.

*this image is generated using AI for illustrative purposes only.
Neogen Chemicals released the audio recording of its analysts and investors conference call held on July 27, 2026, to discuss financial results for the first quarter of fiscal year 2027. The management team addressed stakeholder queries regarding operational and financial performance during the session. Investors can access the recording directly via the company’s official website, ensuring transparency and timely dissemination of material information.
The disclosure was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Neogen Chemicals submitted the notification to both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on July 27, 2026. The filing confirms that the conference call took place at 4:00 p.m. on Monday, July 27, 2026.
Conference Call Details
The company has hosted the audio recording of the earnings call on its digital platform. Investors can access the file directly via the provided link on the Neogen Chemicals website. This step aligns with regulatory requirements for timely dissemination of material information to the investing public.
| Detail | Information |
|---|---|
| Event | Analysts/Investors Conference Call |
| Date | July 27, 2026 |
| Time | 4:00 p.m. |
| Regulation | Regulation 30 of SEBI LODR 2015 |
| Access | Company Website |
Regulatory Compliance
Unnati Kanani, Company Secretary and Compliance Officer of Neogen Chemicals, signed the disclosure letter. The document was digitally signed and timestamped on July 27, 2026, at 18:31:31 IST. The submission includes the company's scrip code on BSE (542665) and debt segment code (977028), as well as its symbol on NSE (NEOGEN).
What the Numbers Show
While the specific financial metrics were discussed during the call, the primary purpose of this filing is to provide access to the full transcript of management's commentary. Stakeholders are advised to review the audio recording for detailed insights into revenue trends, margin dynamics, and forward-looking guidance provided by the executive team during the session.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.40% | +9.90% | +4.14% | +68.96% | +58.91% | +138.67% |
What specific revenue growth targets or margin expansion goals did Neogen Chemicals' management outline for the remainder of fiscal year 2027?
How might the operational insights shared in the Q1 FY27 call influence Neogen's valuation relative to its peers in the specialty chemicals sector?
Are there any new product launches or capacity expansion projects mentioned that could drive long-term earnings visibility beyond the current quarter?

































